Financial Incentives Increase Viral Suppression in HIV

Share this content:
Financial Incentives Increase Viral Suppression in HIV
Financial Incentives Increase Viral Suppression in HIV

TUESDAY, June 20, 2017 (HealthDay News) -- For HIV-positive patients, financial incentives increase viral suppression, according to a study published online June 19 in JAMA Internal Medicine.

Wafaa M. El-Sadr, M.D., from Columbia University in New York City, and colleagues conducted a large community-based clinical trial that randomized 37 HIV test and 39 HIV care sites to financial incentives or standard of care.

The researchers found that financial incentives did not increase linkage to care within three months, as indicated by CD4+ and/or viral load test results done at a care site (adjusted odds ratio, 1.10; 95 percent confidence interval, 0.73 to 1.67; P = 0.65). However, there was a correlation for financial incentives with increased viral suppression. Compared with standard-of-care sites, at financial-incentive sites the overall proportion of patients with viral suppression was 3.8 percent higher (95 percent confidence interval, 0.7 to 6.8 percent; P = 0.01). At financial-incentive sites, the proportion of patients virally suppressed was 4.9 percent higher (95 percent confidence interval, 1.4 to 8.5 percent; P = 0.007) among patients not previously consistently virally suppressed. At financial-incentive sites, continuity in care was 8.7 percent higher (95 percent confidence interval, 4.2 to 13.2 percent; P < 0.001).

"Financial incentives offer promise for improving adherence to treatment and viral suppression among HIV-positive patients," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Mortality Estimates Favor Annual Mammography From Age 40

Mortality Estimates Favor Annual Mammography From Age 40

Researchers estimate thousands of U.S. lives would be saved each year if mammograms started at age 40

Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

Even if pregnant women later hear better info from doctors, they may still wait on vaccines

Hours Worked Impacted by Kids for Female, Not Male Doctors

Hours Worked Impacted by Kids for Female, Not ...

Findings from a national sample of dual-physician couples

is free, fast, and customized just for you!

Already a member?

Sign In Now »